DYN NASDAQ
Dyne Therapeutics, Inc.
1W: -5.0%
1M: -11.7%
3M: +16.7%
YTD: -6.1%
1Y: +40.8%
3Y: +30.1%
5Y: -0.6%
$17.37
+0.00 (+0.00%)
Weekly Expected Move ±7.8%
$15
$16
$17
$19
$20
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q1 2026268
Institutions Holding
+4 vs prior
97.7%
Ownership
-21.96%
37
New
93
Increased
117
Reduced
68
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-05-06 | Rhodes Jason P | director | S-Sale | 17,244 | $18.18 | $313K | Filing |
| 2026-05-06 | Rhodes Jason P | director | S-Sale | 428 | $18.18 | $8K | Filing |
| 2026-05-06 | Rhodes Jason P | director | S-Sale | 43,621 | $18.18 | $793K | Filing |
| 2026-05-06 | Rhodes Jason P | director | S-Sale | 21,926 | $18.18 | $399K | Filing |
| 2026-05-05 | Rhodes Jason P | director | S-Sale | 2,403 | $18.03 | $43K | Filing |
| 2026-05-05 | Rhodes Jason P | director | S-Sale | 60 | $18.03 | $1K | Filing |
| 2026-05-05 | Rhodes Jason P | director | S-Sale | 6,081 | $18.03 | $110K | Filing |
| 2026-05-05 | Rhodes Jason P | director | S-Sale | 3,056 | $18.03 | $55K | Filing |
| 2026-05-04 | Rhodes Jason P | director | S-Sale | 2,466 | $18.00 | $44K | Filing |
| 2026-05-04 | Rhodes Jason P | director | S-Sale | 61 | $18.00 | $1K | Filing |
| 2026-05-04 | Rhodes Jason P | director | S-Sale | 6,241 | $18.00 | $112K | Filing |
| 2026-05-04 | Rhodes Jason P | director | S-Sale | 3,136 | $18.00 | $56K | Filing |
| 2026-04-28 | Rhodes Jason P | director | S-Sale | 21 | $19.00 | $399 | Filing |
| 2026-04-28 | Rhodes Jason P | director | S-Sale | 1 | $19.00 | $19 | Filing |
| 2026-04-28 | Rhodes Jason P | director | S-Sale | 52 | $19.00 | $988 | Filing |
| 2026-04-28 | Rhodes Jason P | director | S-Sale | 26 | $19.00 | $494 | Filing |
| 2026-04-28 | Rhodes Jason P | director | S-Sale | 47,082 | $18.38 | $865K | Filing |
| 2026-04-28 | Rhodes Jason P | director | S-Sale | 1,170 | $18.38 | $22K | Filing |
| 2026-04-28 | Rhodes Jason P | director | S-Sale | 119,115 | $18.38 | $2.2M | Filing |
| 2026-04-28 | Rhodes Jason P | director | S-Sale | 59,870 | $18.38 | $1.1M | Filing |
| 2026-04-27 | Rhodes Jason P | director | S-Sale | 90,943 | $18.15 | $1.7M | Filing |
| 2026-04-27 | Rhodes Jason P | director | S-Sale | 35,947 | $18.15 | $652K | Filing |
| 2026-04-27 | Rhodes Jason P | director | S-Sale | 894 | $18.15 | $16K | Filing |
| 2026-04-27 | Rhodes Jason P | director | S-Sale | 45,709 | $18.15 | $830K | Filing |
| 2026-04-24 | Rhodes Jason P | director | S-Sale | 710 | $18.48 | $13K | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| Lion Point Capital, LP | 18,000 | $326M | — | 2026-03-31 | Filing |
| JANUS HENDERSON GROUP PLC | 13,647,376 | $247M | -240,346 | 2026-03-31 | Filing |
| BlackRock, Inc. | 11,699,870 | $212M | +509,032 | 2026-03-31 | Filing |
| Atlas Venture Life Science Advisors, LLC | 9,130,465 | $166M | — | 2026-03-31 | Filing |
| FMR LLC | 8,908,980 | $162M | +2,339,059 | 2026-03-31 | Filing |
| Orbis Allan Gray Ltd | 6,762,231 | $123M | +1,960,303 | 2026-03-31 | Filing |
| STATE STREET CORP | 6,653,746 | $121M | -38,999 | 2026-03-31 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 6,405,069 | $116M | +6,405,069 | 2026-03-31 | Filing |
| FCPM III SERVICES B.V. | 4,644,386 | $84M | -818,460 | 2026-03-31 | Filing |
| TCG Crossover Management, LLC | 4,615,144 | $84M | — | 2026-03-31 | Filing |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4,162,041 | $75M | +4,162,041 | 2026-03-31 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 3,504,114 | $64M | +240,685 | 2026-03-31 | Filing |
| ARMISTICE CAPITAL, LLC | 3,175,110 | $58M | -74,598 | 2026-03-31 | Filing |
| Frazier Life Sciences Management, L.P. | 3,153,082 | $57M | — | 2026-03-31 | Filing |
| JPMORGAN CHASE & CO | 3,253,473 | $56M | -296,436 | 2026-03-31 | Filing |
| ORBIMED ADVISORS LLC | 2,917,884 | $53M | +715,700 | 2026-03-31 | Filing |
| Siren, L.L.C. | 2,229,125 | $40M | -1,273,816 | 2026-03-31 | Filing |
| FRANKLIN RESOURCES INC | 2,009,082 | $36M | +2,444 | 2026-03-31 | Filing |
| Deep Track Capital, LP | 2,000,000 | $36M | -650,000 | 2026-03-31 | Filing |
| SAMLYN CAPITAL, LLC | 1,922,543 | $35M | +429,468 | 2026-03-31 | Filing |